Abstract

Although chemotherapy is mostly performed by direct injection of the chemotherapeutic agents systemically, this approach can cause undesirable side effects in normal tissues and lacks targeting efficiency. In this study, we have developed a micron-sized, bead-type multifunctional anticancer-drug carrier that can be injected in the vicinity of a lesion using a syringe. The multifunctional anticancer-drug carrier bead was fabricated by incorporating functional nanomaterials, such as near-infrared (NIR)-responsive gold nanorod (GNR) and superparamagnetic iron oxide nanoparticles (IONP) that work as a magnetic resonance imaging (MRI) contrast agent, into an alginate hydrogel bead. The carrier bead containing GNR and IONP was spherical, with an average size of 362.2 ± 22.7 µm. These multifunctional anticancer-drug carrier beads could successfully release doxorubicin (Dox) into the external environment upon irradiation with an NIR laser. The laser responsive on-demand release profile demonstrated well-controlled and sustained release of Dox, and the effectiveness of this drug delivery system can be confirmed in vitro by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay. Additionally, the control experiments evidenced that the thermal effect of GNR was insignificant and the cytotoxic action of Dox was expressed only after irradiation with the NIR laser. The multifunctional anticancer-drug carrier beads can be precisely monitored with the MRI T2 imaging mode.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.